Resultados de búsqueda - "Immunotherapy"

Limitar resultados
  1. Immunoprophylaxis against African trypanosomiasis por Murray, M., Urquhart, G.M.

    Publicado 1977
    Materias: “…immunotherapy…”
    Enlace del recurso
    Capítulo de libro
  2. Sommareksem hos islandshäst : patogenes och behandlingsmöjligheter por Moe, Anna

    Publicado 2016
    Materias: “…immunotherapy…”
    M2
  3. Whole exome-seq and RNA-seq data reveal unique neoantigen profiles in Kenyan breast cancer patients por Wagutu, G., Gitau, J., Mwangi, Kennedy, Murithi, M., Melly, E., Harris, A.R., Sayed, S., Ambs, S., Makokha, F.

    Publicado 2024
    “…Background: The immune response against tumors relies on distinguishing between self and non-self, the basis of cancer immunotherapy. Neoantigens from somatic mutations are central to many immunotherapeutic strategies and understanding their landscape in breast cancer is crucial for targeted interventions. …”
    Enlace del recurso
    Journal Article
  4. Utvärtes behandling av sarkoider på häst med Aldara TM eller Xxterra TM por Pettersson, Carina

    Publicado 2008
    “…Aldara™ is a verified immunotherapy, whereas the exact mechanism of action for Xxterra™ is not verified, though according to the producer Xxterra™ is also an immunotherapy. …”
    Enlace del recurso
    Otro
  5. In vitro inhibitory activity of IgY antibodies against Salmonella ser. newport isolated from horses por Bustos, Carla Paola, Leiva, Carlos Leónidas, Gambarotta, Mariana, Guida, Nora, Chacana, Pablo

    Publicado 2022
    “…One of these options is the use of specific egg yolk antibodies (IgY) for passive immunotherapy. Thus, the aim of our work was to produce IgY antibodies against an equine S. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Artículo
  6. Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma por Di Sciullo, Maria Paula, Menay, Florencia, Cocozza, Federico, Gravisaco, María José, Waldner, Claudia Inés, Mongini, Claudia

    Publicado 2019
    “…Systemic administration of imiquimod proved to have high potential to serve as a vaccine adjuvant for the treatment of T-cell lymphomas and was effective in this immunotherapy model.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Artículo
  7. Hästens hudproblem por Hoyle, Christina

    Publicado 2011
    “…Local treatment with Immunomodulating substances represents 50,7 % of treatments, followed by systemic corticosteroids (14,1 %), allergen specific Immunotherapy (ASIT) (12 %), antihistamine (11,3 %) and systemic and local antibiotics in 4,9 and 2,8 % of the cases, respectively. …”
    Enlace del recurso
    Second cycle, A1N, A1F or AXX
  8. The WT1-gene – its role in tumourigenesis and prospects for developing a vaccine por Lindstedt, Ingrid

    Publicado 2014
    “…This information can then be used to develop immunotherapy (vaccines) to stabilize and treat different tumours and cancer forms. …”
    Enlace del recurso
    First cycle, G2E
  9. Exosomes Isolated from Ascites of T-Cell Lymphoma-Bearing Mice Expressing Surface CD24 and HSP-90 Induce a Tumor-Specific Immune Response por Menay, Florencia, Herschlik, Leticia, De Toro, Julieta, Cocozza, Federico, Tsacalian, Rodrigo Farid, Gravisaco, Marí­a José, Di Sciullo , Maria Paula, Vendrell, Alejandrina, Waldner, Claudia Inés, Mongini, Claudia

    Publicado 2017
    “…Due to these characteristics, EVs have shown potential as a new alternative for cancer immunotherapy. Tumor exosomes isolated from malignant ascites can activate dendritic cells, thereby priming the immune system to recognize and kill cancer cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Artículo

Herramientas de búsqueda: